Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 287

Similar articles for PubMed (Select 17913855)

1.

The relevance of estrogen receptor-beta expression to the antiproliferative effects observed with histone deacetylase inhibitors and phytoestrogens in prostate cancer treatment.

Stettner M, Kaulfuss S, Burfeind P, Schweyer S, Strauss A, Ringert RH, Thelen P.

Mol Cancer Ther. 2007 Oct;6(10):2626-33. Epub 2007 Oct 3.

2.

Expressional changes after histone deacetylase inhibition by valproic acid in LNCaP human prostate cancer cells.

Thelen P, Schweyer S, Hemmerlein B, Wuttke W, Seseke F, Ringert RH.

Int J Oncol. 2004 Jan;24(1):25-31.

PMID:
14654937
3.

Phytoestrogens from Belamcanda chinensis regulate the expression of steroid receptors and related cofactors in LNCaP prostate cancer cells.

Thelen P, Peter T, Hünermund A, Kaulfuss S, Seidlová-Wuttke D, Wuttke W, Ringert RH, Seseke F.

BJU Int. 2007 Jul;100(1):199-203. Epub 2007 May 4.

PMID:
17488304
4.

[Pharmacological potential of phytoestrogens in the treatment of prostate cancer].

Thelen P, Seseke F, Ringert RH, Wuttke W, Seidlová-Wuttke D.

Urologe A. 2006 Feb;45(2):195-6, 197-201. German.

PMID:
16237540
5.

Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells.

Suenaga M, Soda H, Oka M, Yamaguchi A, Nakatomi K, Shiozawa K, Kawabata S, Kasai T, Yamada Y, Kamihira S, Tei C, Kohno S.

Int J Cancer. 2002 Feb 10;97(5):621-5.

PMID:
11807787
6.

Metallothionein is up-regulated under hypoxia and promotes the survival of human prostate cancer cells.

Yamasaki M, Nomura T, Sato F, Mimata H.

Oncol Rep. 2007 Nov;18(5):1145-53.

PMID:
17914565
7.

Inhibitory effect of isoflavones on prostate cancer cells and PTEN gene.

Cao F, Jin TY, Zhou YF.

Biomed Environ Sci. 2006 Feb;19(1):35-41.

PMID:
16673816
8.

Stimulation of endometrial glandular cells with genistein and daidzein and their effects on ERalpha- and ERbeta-mRNA and protein expresion.

Staar S, Richter DU, Makovitzky J, Briese V, Bergemann C.

Anticancer Res. 2005 May-Jun;25(3A):1713-8.

9.
10.

Tectorigenin and other phytochemicals extracted from leopard lily Belamcanda chinensis affect new and established targets for therapies in prostate cancer.

Thelen P, Scharf JG, Burfeind P, Hemmerlein B, Wuttke W, Spengler B, Christoffel V, Ringert RH, Seidlová-Wuttke D.

Carcinogenesis. 2005 Aug;26(8):1360-7. Epub 2005 Apr 21.

11.

Expression of oestrogen receptor-alpha and oestrogen receptor-beta in prostate cancer.

Yang GS, Wang Y, Wang P, Chen ZD.

Chin Med J (Engl). 2007 Sep 20;120(18):1611-5.

PMID:
17908481
12.

Distinct mRNA, protein expression patterns and distribution of oestrogen receptors alpha and beta in human primary breast cancer: correlation with proliferation marker Ki-67 and clinicopathological factors.

Jarzabek K, Koda M, Kozlowski L, Mittre H, Sulkowski S, Kottler ML, Wolczynski S.

Eur J Cancer. 2005 Dec;41(18):2924-34. Epub 2005 Nov 10.

PMID:
16289616
13.

Chronic administration of valproic acid inhibits prostate cancer cell growth in vitro and in vivo.

Xia Q, Sung J, Chowdhury W, Chen CL, Höti N, Shabbeer S, Carducci M, Rodriguez R.

Cancer Res. 2006 Jul 15;66(14):7237-44.

14.

Involvement of the estrogen receptor beta in genistein-induced expression of p21(waf1/cip1) in PC-3 prostate cancer cells.

Matsumura K, Tanaka T, Kawashima H, Nakatani T.

Anticancer Res. 2008 Mar-Apr;28(2A):709-14.

15.
16.

ERalpha and ERbeta expression and transcriptional activity are differentially regulated by HDAC inhibitors.

Duong V, Licznar A, Margueron R, Boulle N, Busson M, Lacroix M, Katzenellenbogen BS, Cavaillès V, Lazennec G.

Oncogene. 2006 Mar 16;25(12):1799-806.

17.

Valproic acid activity in androgen-sensitive and -insensitive human prostate cancer cells.

Iacopino F, Urbano R, Graziani G, Muzi A, Navarra P, Sica G.

Int J Oncol. 2008 Jun;32(6):1293-303.

PMID:
18497991
18.

New histone deacetylase inhibitors as potential therapeutic tools for advanced prostate carcinoma.

Wedel SA, Sparatore A, Soldato PD, Al-Batran SE, Atmaca A, Juengel E, Hudak L, Jonas D, Blaheta RA.

J Cell Mol Med. 2008 Dec;12(6A):2457-66. doi: 10.1111/j.1582-4934.2008.00271.x. Epub 2008 Feb 8.

PMID:
18266964
19.

Valproic acid induces neuroendocrine differentiation and UGT2B7 up-regulation in human prostate carcinoma cell line.

Valentini A, Biancolella M, Amati F, Gravina P, Miano R, Chillemi G, Farcomeni A, Bueno S, Vespasiani G, Desideri A, Federici G, Novelli G, Bernardini S.

Drug Metab Dispos. 2007 Jun;35(6):968-72. Epub 2007 Mar 19.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk